You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Unknown Primary Squamous Cell Carcinoma

Showing 9926 - 9950 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer Trial in Seoul (cell free DNA in blood, genetic mutation in tissue)

Recruiting
  • Pancreatic Cancer
  • cell free DNA in blood, genetic mutation in tissue
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Nov 2, 2022

HPV Testing for Cervical Cancer Screening in Women Living With

Recruiting
  • HIV Seropositivity
    • Saint-Denis, France
      Centre Hospitalier de Saint-Denis
    Jul 20, 2023

    Calcific Aortic Valve Disease:Multidisciplinary Approach to

    Recruiting
    • Calcific Aortic Valve Diasease
    • Analysis of calcific aortic valves
    • Pavia, Italy
      Fondazione IRCCS Policlinico San MAtteo
    Apr 11, 2023

    Gastrointestinal Stromal Tumors Trial in Beijing (68Ga-NOTA-RM26)

    Recruiting
    • Gastrointestinal Stromal Tumors
    • Beijing, Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medica
    Aug 6, 2021

    Breast Cancer Trial in Gaia (Combined Aerobic and Resistance Exercise)

    Not yet recruiting
    • Breast Cancer
    • Combined Aerobic and Resistance Exercise
    • Gaia, Porto, Portugal
      Centro Hospitalar Vila Nova Gaia e Espinho
    Jul 27, 2023

    Giant Cell Arteritis - Optimization of Diagnostics

    Recruiting
    • Giant Cell Arteritis
    • Giant cell arteritis
    • Copenhagen, Denmark
      Rigshospitalet
    Feb 10, 2022

    Pulpitis - Irreversible Trial (Fanta AF blue rotary files 20 taper 4, Fanta AF baby rotary files 20 , 25 , 30 taper 4)

    Not yet recruiting
    • Pulpitis - Irreversible
    • Fanta AF blue rotary files 20 taper 4
    • Fanta AF baby rotary files 20 , 25 , 30 taper 4
    • (no location specified)
    Nov 24, 2023

    Bone Diseases, Pain Trial run by the NIDCR (Denosumab)

    Active, not recruiting
    • Bone Diseases
    • Pain
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 17, 2022

    High Risk Neuroblastoma Trial in United States (biological, other, drug)

    Completed
    Has Results
    • High Risk Neuroblastoma
    • Aldesleukin
    • +4 more
    • Loma Linda, California
    • +31 more
    Jul 30, 2021

    Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa Trial in Westport, Coral Springs, Dubai (Arm 1)

    Recruiting
    • Retinal Disease
    • +17 more
    • Arm 1
    • Westport, Connecticut
    • +2 more
    Nov 25, 2022

    Effect of DAAs on Behavior of HCC in HCV Patients

    Completed
    • Carcinoma, Hepatocellular
    • Hepatitis C
      • Cairo, Egypt
      • +2 more
      Jul 19, 2021

      Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using

      Active, not recruiting
      • Non Small Cell Lung Cancer
      • therascreen® KRAS RGQ PCR Kit
      • Manchester, United Kingdom
        QIAGEN Gaithersburg, Inc
      Sep 26, 2022

      Skin Cancer, Non-melanoma Skin Cancer, Sun Damaged Skin Trial in Phoenix (Levulan® Kerastick®, BLU-U Blue Light Photodynamic

      Recruiting
      • Skin Cancer
      • +3 more
      • Levulan® Kerastick®
      • BLU-U Blue Light Photodynamic Therapy
      • Phoenix, Arizona
        Medical Dermatology Specialists
      May 3, 2021

      Postmenopausal Osteoporosis Trial (Romosozumab)

      Not yet recruiting
      • Postmenopausal Osteoporosis
      • (no location specified)
      Oct 16, 2023

      Treatment Resistant Depression Trial in Paris (Transcranial Ultrasonic Stimulation prototype)

      Recruiting
      • Treatment Resistant Depression
      • Transcranial Ultrasonic Stimulation prototype
      • Paris, France
        GHU Sainte-Anne
      Oct 10, 2023

      Auricular Acupressure, Cervical Spine Surgery Trial in Taipei (Arms and Interventions)

      Completed
      • Auricular Acupressure
      • Cervical Spine Surgery
      • Arms and Interventions
      • Taipei, Taiwan
        Taipei veterans general hospital
      Oct 12, 2023

      The Patient's First Point of Contact

      Recruiting
      • Nurse-Patient Relations
      • Observations to investigate the current practices of communication and decision-making during Nurse-patient consultations
      • Borås, Sweden
        University of Borås
      Oct 2, 2023

      Primary Breast Cancer Trial (SPECT)

      Not yet recruiting
      • Primary Breast Cancer
      • (no location specified)
      Jun 19, 2023

      Breast Cancer Female Trial in Tomsk ([99mTc]Tc-G3-(G3S)3C)

      Enrolling by invitation
      • Breast Cancer Female
      • Tomsk, Russian Federation
        Olga
      Jun 19, 2023

      SMN Circular RNAs as Potential Biomarkers for Therapeutic

      Recruiting
      • Spinal Muscular Atrophy
        • Rome, Italy/rome, Italy
          ethics committee of IRCCS Fondazione Policlinico Gemelli
        Mar 10, 2023

        Role of Gut Microbiome in Cancer Therapy

        Active, not recruiting
        • Hematopoietic and Lymphoid Cell Neoplasm
        • Malignant Solid Neoplasm
        • Biospecimen Collection
        • Electronic Health Record Review
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Jan 18, 2023

        Myelodysplastic Syndrome (MDS) Trial in Worldwide (sabatolimab, azacitidine, venetoclax)

        Active, not recruiting
        • Myelodysplastic Syndrome (MDS)
        • Brasschaat, Belgium
        • +9 more
        Jan 19, 2023

        Small Cell Lung Cancer Trial in Worldwide (Pembrolizumab, MK-4830, MK-5890)

        Recruiting
        • Small Cell Lung Cancer
        • Pembrolizumab
        • +6 more
        • Gilbert, Arizona
        • +48 more
        Jan 19, 2023

        NSCLC, Carcinoma Breast Trial in Suzhou (Vinorelbine, Radiotherapy, PD-1/PD-L1 inhibitor)

        Not yet recruiting
        • Carcinoma, Non-Small-Cell Lung
        • Carcinoma Breast
        • Suzhou, China
          Second Affiliated Hospital of Soochow University
        Oct 29, 2022

        NSCLC Trial in Philadelphia (Pembrolizumab)

        Active, not recruiting
        • Non-small Cell Lung Cancer
        • Philadelphia, Pennsylvania
          Abramson Cancer Center of the University of Pennsylvania
        Nov 1, 2022